Join the Tuberculosis group to help and get support from people like you.
Tuberculosis News
Related terms: TB
Shortened BDLC Regimen Not Noninferior for Drug-Resistant TB
TUESDAY, July 22, 2025 – For preextensively drug resistant tuberculosis (TB), a shortened bedaquiline, delamanid, linezolid, and clofazimine (BDLC) regimen is not noninferior to longer standard of...
Tuberculosis Is Back on the Rise: What To Know About Symptoms and Treatment
TUEDSAY, July 16, 2025 — Tuberculosis (TB) was the leading cause of death in the United States in the 19th and 20th centuries. By 1900, TB — which usually attacks the lungs but can affect almost any p...
More Than 14 Million Will Die Following U.S. Foreign Aid Cuts
MONDAY, July 7, 2025 — More than 14 million children and adults will die from preventable causes during the next five years as a result of U.S. foreign aid cuts, a new study projects. Programs s...
Jail Time Increases A Person's Risk of Death
THURSDAY, June 5, 2025 — Jail time has a huge effect on both an individual’s and a community’s long-term health, even after their release, a new study says. People serving time are 39% more likely to ...
BCG Revaccination Does Not Provide Protection From Sustained Mycobacterium Tuberculosis Infection
MONDAY, May 12, 2025 – Bacille Calmette-Guérin (BCG) revaccination is not efficacious for preventing sustained Mycobacterium tuberculosis infection, defined by sustained QuantiFERON-TB (QFT) test ...
TB Cases Go Undetected In Prisons, Threatening Nearby Communities
TUESDAY, April 8, 2025 – Tuberculosis (TB) might seem like a disease from days gone by, but a new study suggests the COVID pandemic might have given the infectious menace a new foothold. Most...
Tuberculosis on the Rise Again in the United States
WEDNESDAY, March 26, 2025 – Preliminary data released this month by the U.S. Centers for Disease Control and Prevention indicate that more than 10,300 tuberculosis (TB) cases were reported last...
Three All-Oral Shortened Regimens Noninferior for Rifampin-Resistant TB
THURSDAY, Feb. 6, 2025 – Three all-oral shortened regimens have noninferior efficacy compared with standard therapy for fluoroquinolone-susceptible, rifampin-resistant tuberculosis, according to a...
Health Officials Alarmed by Tuberculosis Outbreak in Kansas
TUESDAY, Jan. 28, 2025 – Kansas health officials are tackling the largest tuberculosis (TB) outbreak in U.S. history, with 67 confirmed cases since the start of 2025. The outbreak includes 60 active...
Kansas Reports Largest Tuberculosis Outbreak in U.S. History
TUESDAY, Jan. 28, 2025 – Kansas health officials are fighting the largest tuberculosis (TB) outbreak in U.S. history, with 67 confirmed cases since new year began. The outbreak includes 60 active...
Shorter Treatment Regimens Recommended for Tuberculosis
MONDAY, Jan. 13, 2025 – In a clinical practice guideline issued by the American Thoracic Society and published in the January issue of the American Journal of Respiratory and Critical Care Medicine,...
Global TB Cases Hit Record High, TB Becomes Top Infectious Disease Killer
WEDNESDAY, Oct. 30, 2024 – The World Health Organization reports that tuberculosis (TB) cases hit a record high in 2023, with more than 8 million diagnoses and 1.25 million deaths, meaning it is...
Once Again, Tuberculosis Becomes World's Top Infectious Disease Killer
WEDNESDAY, Oct. 30, 2024 – In the highest tally ever recorded for tuberculosis cases, the World Health Organization reported Tuesday that over 8 million people worldwide were diagnosed with the lung...
FDA Approves New Pediatric Formulation of Sirturo (bedaquiline) as Part of Combination Therapy to Treat Children with Pulmonary Multidrug-Resistant Tuberculosis
NEW BRUNSWICK, NJ, May 27, 2020 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric f...
FDA Approves Pretomanid for Highly Drug-Resistant Forms of Tuberculosis
NEW YORK August 14, 2019 - Pretomanid, a novel compound developed by the non-profit organization TB Alliance, was approved by the U.S. Food & Drug Administration (FDA) today for treating some of the...